NIMI
BLUE

Natixis Investment Managers International’s bluebird bio BLUE Stock Holding History

Natixis Investment Managers International’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-226
Closed -$428K – 94
2018
Q3 		$428K Sell
226
-226
-50% -$467K 0.02% 503
2018
Q2 		$920K Hold
452
– – 0.05% 296
2018
Q1 		$1M Buy
452
+219
+94% +$557K 0.07% 178
2017
Q4 		$538K Sell
233
-495
-68% -$1M 0.06% 109
2017
Q3 		$1.29M Buy
728
+515
+242% +$720K 0.11% 128
2017
Q2 		$290K Buy
+213
New +$257K 0.03% 287

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Natixis Investment Managers International's BLUE Position: Q4 2018 in Review

Natixis Investment Managers International sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 226 shares — an estimated $428K sold.

Natixis Investment Managers International first reported a position in BLUE in Q2 2017 and held it in 6 quarters. The position peaked at $1.29M in Q3 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Natixis Investment Managers International reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 226 bluebird bio shares in Q4 2018, an estimated $428K.
  • Natixis Investment Managers International first reported a position in bluebird bio in Q2 2017 and held it in 6 quarters.
  • Natixis Investment Managers International's bluebird bio position peaked at $1.29M in Q3 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Natixis Investment Managers International's 13F filing for Q4 2018, filed 14 Feb 2019.